Strategic Partnerships Leverage Perimeter's AI and intraoperative OCT capabilities announced in collaboration with the University of Toronto to explore co-development and integration opportunities with prominent surgical device distributors and hospital systems focusing on real-time imaging for cancer surgery.

Clinical Adoption Target ASBrS attendees and other leading surgical societies where Perimeter has demonstrated products like Claire OCT+AI, to drive on-site demonstrations, case studies, and payer-friendly outcomes to shorten adoption cycles.

Geographic Expansion Capitalize on dual headquarters in Toronto and Dallas to pursue U.S. FDA readiness, hospital network pilots, and North American sales motions, aligning with mid-market cancer centers seeking advanced imaging with AI insights.

Economic Proof Highlight current revenue range and solid funding to reassure buyers of financial stability and scale potential, while offering tiered deployment models and ROI calculators that illustrate cost reductions and improved margin through real-time decision support.

Market Positioning Position Claire OCT+AI as a scalable platform in the competitive landscape with clinicians, focusing on high-resolution intraoperative imaging and AI analytics to differentiate from incumbents and attract partnerships with AI/medical imaging integrators.